Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review

Agitation is one of the most challenging neuropsychiatric symptoms to treat in Alzheimer’s disease and has significant implications for patient and caregiver. A major source of difficulty in identifying safe and effective treatments for agitation is the lack of validated biomarkers. As such, patients may not be appropriately targeted, and Read & Research Alzheimer’s More

Leave a Reply